“…The antiproliferative effects have garnered particular interest in the treatment of neoplasms, where levels of agmatine are lower than in the surrounding normal tissue (48). Agmatine suppresses growth through the reduction of intracellular polyamine levels, which are required for growth, and inhibition of ornithine decarboxylase (ODC), the first and rate-limiting enzyme of polyamine biosynthesis, in all models studied to date (4,16,22,29,46,59,68). Reduction of cellular polyamine levels occurs by the induction of the polyamine autoregulatory protein antizyme (4,29,59), increasing activity of polyamine catabolism (16,68), and/or decreasing ODC activity by another mechanism, possibly by reduction of ODC translation (4,71).…”